EKF Diagnostics Holdings PLC Director/PDMR Shareholding (5081E)
July 18 2016 - 11:06AM
UK Regulatory
TIDMEKF
RNS Number : 5081E
EKF Diagnostics Holdings PLC
18 July 2016
EKF Diagnostics Holdings plc
("EKF" or the "Company")
Notification of transactions by Persons Discharging Managerial
Responsibilities and persons closely associated with them
EKF Diagnostics Holdings plc (AIM: EKF) announces that on 18
July 2016, the Company was notified that Harwood Capital LLP
("Harwood") acquired 9,000,000 ordinary shares of 1 pence each in
the capital of the Company ("Ordinary Shares") as investment
manager to North Atlantic Smaller Companies Investment Trust PLC
("NAIT"). Christopher Mills, the Company's Non-Executive Chairman,
is a partner and Chief Investment Officer of Harwood and a director
and shareholder in NAIT.
Following the above transaction, which was completed on 15 July
2016 at a price of 14.89 pence per share, NAIT's interest is now in
87,100,000 Ordinary Shares, representing 18.76% of the Company's
issued share capital. The interests of Oryx International Growth
Fund Limited ("Oryx", whose investment adviser is Harwood) remains
as previously disclosed in 40,000,000 Ordinary Shares, representing
8.62% of the Company's issued share capital. Mr Mills is also a
director and shareholder in Oryx.
The total indirect beneficial interest of Mr Mills is, following
the above transaction, therefore now in 127,100,000 Ordinary
Shares, representing 27.38% of the Company's issued share
capital.
EKF Diagnostics Holdings plc Tel: 029 2071 0570
Julian Baines, CEO
Richard Evans, FD & COO
Panmure Gordon (UK) Limited Tel: 020 7886 2500
Paul Fincham
Peter Steel
Walbrook PR Limited Tel: 020 7933 8780 or ekf@walbrookpr.com
Paul McManus Mob: 07980 541 893
Lianne Cawthorne Mob: 07584 391 303
This notification is made in accordance with the requirements of
the EU Market Abuse Regulation. Further details:
Initial notification / amendment: Initial
Ordinary Shares Identification Code: ISIN GB0031509804
Aggregated information: N/A
Place of the transaction: London Stock Exchange, AIM (XLON)
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBUGDRUGBBGLI
(END) Dow Jones Newswires
July 18, 2016 11:06 ET (15:06 GMT)
Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Apr 2023 to Apr 2024